Public health advocates warn of conflicts of interests and say panel likely to provide justification for key rollbacks
The Trump administration has stacked a top chemical safety board with industry-aligned scientists who have a range of financial conflicts of interest and stand to profit from deregulation, public health advocates say.
The Environmental Protection Agency’s science advisory committee on chemicals (SACC) is slated to review research for dozens of toxic chemicals during the new members’ terms. At least 13 proposed Trump appointees are probably conflicted on the chemicals that will be reviewed, comments filed with the EPA by a coalition of public health advocacy groups alleges.